Methylated SYDE1 was demonstrated to be significantly associated with the relapse-free survival of patients with breast cancer (26) However, there are currently no studies regarding the implications of SLURP1 and SYDE2 in cervical cancer. The gene discussed is SYDE2; the disease is cervical carcinoma.